In Vivo Behavior of Liposomes: Interactions with the Mononuclear Phagocyte System and Implications for Drug Targeting
10.1007/978-3-642-75862-1_8
Crossref book-chapter
Springer Berlin Heidelberg
Handbook of Experimental Pharmacology (297)
Bibliography

Scherphof, G. L. (1991). In Vivo Behavior of Liposomes: Interactions with the Mononuclear Phagocyte System and Implications for Drug Targeting. Targeted Drug Delivery, 285–327.

Authors 1
  1. G. L. Scherphof (first)
References 255 Referenced 22
  1. Abra RM, Hunt CA (1981) Liposome disposition in vivo. III. Dose and vesicle size effects. Biochim Biophys Acta 666: 493–503 / Liposome disposition in vivo. III by RM Abra (1981)
  2. Abra RM, Bosworth ME, Hunt CA (1980) Liposome disposition in vivo: effects of predosing with liposomes. Res Commun Chem Pathol Pharmacol 29: 349–359. / Res Commun Chem Pathol Pharmacol by RM Abra (1980)
  3. Abra RM, Hunt CA, Fu KK, Peters JH (1983) Delivery of therapeutic doses of doxorubicin to the mouse lung using lung-accumulating liposomes proves unsuccessful. Cancer Chemother Pharmacol 11: 98–101 / Cancer Chemother Pharmacol by RM Abra (1983)
  4. Abraham W, Downing DT (1990) Interaction between corneocytes and stratum corneum lipid liposomes in vitro. Biochim Biophys Acta 1021: 119–125 (10.1016/0005-2736(90)90023-H) / Biochim Biophys Acta by W Abraham (1990)
  5. Abraham W, Wertz PW, Downing DT (1988) Effect of epidermal acylglucosylcer-amides and acylceramides on the morphology of liposomes prepared from stratum corneum lipids. Biochim Biophys Acta 939: 403–408 (10.1016/0005-2736(88)90086-7) / Biochim Biophys Acta by W Abraham (1988)
  6. Agarwal K, Bali A, Gupta CM (1986a) Influence of phospholipid structure on the stability of liposomes in serum. Biochim Biophys Acta 856: 36–40 (10.1016/0005-2736(86)90006-4) / Biochim Biophys Acta by K Agarwal (1986)
  7. Agarwal K, Bali A, Gupta CM (1986b) Effect of phospholipid structure on stability and survival times of liposomes in circulation. Biochim Biophys Acta 883: 468–475 (10.1016/0304-4165(86)90286-2) / Biochim Biophys Acta by K Agarwal (1986)
  8. Allen TM (1981) A study of phospholipid interactions between high density lipo–proteins and small unilamellar vesicles. Biochim Biophys Acta 640: 385–397 (10.1016/0005-2736(81)90464-8) / Biochim Biophys Acta by TM Allen (1981)
  9. Allen TM (1988) Toxicity of drug carriers to the mononuclear phagocyte system. Adv Drug Delivery Rev 2: 55–67 (10.1016/0169-409X(88)90005-1) / Adv Drug Delivery Rev by TM Allen (1988)
  10. Allen TM (1989) Stealth liposomes: avoiding reticuloendothelial uptake. In: Lopez-Berestein G, Fidler IJ (eds) Liposomes in the therapy of infectious diseases and cancer. Liss, New York, p 405 / Liposomes in the therapy of infectious diseases and cancer by TM Allen (1989)
  11. Allen TM, Chonn A (1987) Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett 223: 42–46 (10.1016/0014-5793(87)80506-9) / FEBS Lett by TM Allen (1987)
  12. Allen TM, Cleland LG (1980) Serum-induced leakage of liposome contents. Biochim Biophys Acta 597: 418–426 (10.1016/0005-2736(80)90118-2) / Biochim Biophys Acta by TM Allen (1980)
  13. Allen TM, Everest JM (1983) Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drugs in rats. J Pharmacol Exp Ther 226: 539–544 (10.1016/S0022-3565(25)21638-X) / J Pharmacol Exp Ther by TM Allen (1983)
  14. Allen TM, Mehra T (1989) Recent advances in sustained release of antineoplastic drugs using liposomes which avoid uptake into the reticuloendothelial system. Proc West Pharmacol Soc 32: 111–114 / Proc West Pharmacol Soc by TM Allen (1989)
  15. Allen TM, McAllister L, Mausolf S, Gyorffy E (1981) Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT 6, S 49 and AEX (transport-deficient) cell lines. Biochim Biophys Acta 643: 346–362 (10.1016/0005-2736(81)90080-8) / Biochim Biophys Acta by TM Allen (1981)
  16. Allen TM, Ryan JL, Papahadjopoulos D (1985) Gangliosides reduce leakage of aqueous space markers from liposomes in the presence of human plasma. Biochim Biophys Acta 818: 205–210 (10.1016/0005-2736(85)90571-1) / Biochim Biophys Acta by TM Allen (1985)
  17. Allen TM, Hansen C, Rutledge J (1989) Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta 981: 27–35 (10.1016/0005-2736(89)90078-3) / Biochim Biophys Acta by TM Allen (1989)
  18. Alving CR (1987) Liposomes as carriers for vaccines In: Ostro MJ (ed) Liposomes from biophysics to therapeutics. Dekker, New York, p 195 / Liposomes as carriers for vaccines In: Ostro MJ (ed) Liposomes from biophysics to therapeutics by CR Alving (1987)
  19. Alving CR (1988) Macrophages as targets for delivery of Iiposome-encapsulated antimicrobial agents. Adv Drug Delivery Rev 2: 107–128 (10.1016/0169-409X(88)90007-5) / Adv Drug Delivery Rev by CR Alving (1988)
  20. Alving CR, Steck EA, Chapman WL Jr, Waits VB, Hendricks LD, Swartz GM Jr, Hanson WL (1978) Therapy of leishmaniasis: superior efficacies of Iiposome-encapsulated drugs. Proc Natl Acad Sci USA 75: 2959–2963 (10.1073/pnas.75.6.2959) / Proc Natl Acad Sci USA by CR Alving (1978)
  21. Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 41: 99–128 / Adv Enzymol by G Ashwell (1974)
  22. Baldeschwieler JD (1985) Phospholipid vesicle targeting using synthetic glycolipid and other determinants. Ann NY Acad Sci 446: 349–367 (10.1111/j.1749-6632.1985.tb18413.x) / Ann NY Acad Sci by JD Baldeschwieler (1985)
  23. Bali A, Dhawan S, Gupta CM (1983) Stability of liposomes in the circulation is markedly enhanced by structural modification of their phospholipid component. FEBS Lett 154: 373–377 (10.1016/0014-5793(83)80185-9) / FEBS Lett by A Bali (1983)
  24. Bangham AD, Standish MM, Watkins JC (1965a) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13: 238–252 (10.1016/S0022-2836(65)80093-6) / J Mol Biol by AD Bangham (1965)
  25. Bangham AD, Standish MM, Weissmann G (1965b) The action of steroids and streptolysin S on the permeability of phospholipid structures to cations. J Mol Biol 13: 253–259 (10.1016/S0022-2836(65)80094-8) / J Mol Biol by AD Bangham (1965)
  26. Barber RF, Shek PN (1986) Liposomes and tear fluid. I. Release of vesicle-entrapped carboxyfluorescein. Biochim Biophys Acta 879: 157–163 / Liposomes and tear fluid. I by RF Barber (1986)
  27. Beaumier PL, Hwang KJ (1983) Effect of liposome size on the degradation of bovine sphingomyelin/cholesterol liposomes in the mouse liver. Biochim Biophys Acta 731: 23–30 (10.1016/0005-2736(83)90393-0) / Biochim Biophys Acta by PL Beaumier (1983)
  28. Bisgaier CL, Siebenkas MV, Williams KJ (1989) Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. J Biol Chem 264: 862–866 (10.1016/S0021-9258(19)85022-6) / J Biol Chem by CL Bisgaier (1989)
  29. Black CDV, Gregoriadis G (1976) Interaction of liposomes with blood plasma proteins. Biochem Soc Trans 4: 253–256 (10.1042/bst0040253a) / Biochem Soc Trans by CDV Black (1976)
  30. Black CDV, Watson GJ, Ward RJ (1977) The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. Trans R Soc Trop Med Hyg 71: 550–552 (10.1016/0035-9203(77)90155-9) / Trans R Soc Trop Med Hyg by CDV Black (1977)
  31. Blumenthal R, Ralston E, Dragsten P, Leserman LD, Weinstein JN (1982) Lipid vesicle–cell interactions: analysis of a model for transfer of contents from adsorbed vesicles to cells. Membr Biochem 4: 283–303 (10.3109/09687688209065437) / Membr Biochem by R Blumenthal (1982)
  32. Bonventre PF, Gregoriadis G (1978) Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes. Antimocrob Agents Chemother 13: 1049–1051 (10.1128/AAC.13.6.1049) / Antimocrob Agents Chemother by PF Bonventre (1978)
  33. Brown PM, Silvius JR (1990) Hechanisms of delivery of liposome-encapsulated cytosine arabinoside to CV-1 cells in vitro. Fluorescent and cytohoxiciby studies. Biochim Biophys Acta 1023: 341–351 / Hechanisms of delivery of liposome-encapsulated cytosine arabinoside to CV-1 cells in vitro by PM Brown (1990)
  34. Connor J, Huang L (1985) Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. J Cell Biol 101: 582–589 (10.1083/jcb.101.2.582) / J Cell Biol by J Connor (1985)
  35. Coune A, Sculier JP, Fruehling J, Stryckmans P, Brassine C, Ghanem G, Laduron C, Atassi G, Ruysschaert JM, Hildebrand J (1983) IV administration of water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to man. Cancer Treat Rep 67: 1031–1033 / IV administration of water-insoluble antimitotic compound entrapped in liposomes by A Coune (1983)
  36. Daemen T, Veninga A, Roerdink FH, Scherphof GL (1986a) In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Cancer Res 46: 4330–4335 / Cancer Res by T Daemen (1986)
  37. Daemen T, Veninga A, Scherphof GL, Roerdink FH (1986b) The activation of Kupffer cells to tumorcytotoxicity with immunomodulators encapsulated in liposomes. In: Kirn A, Knook DL, Wisse E (eds) Cells of the hepatic sinusoid. Kupffer Cell Foundation, Rijswijk, p 379 / Cells of the hepatic sinusoid by T Daemen (1986)
  38. Daemen T, Veninga A, Roerdink FH, Scherphof GL (1989) Conditions controlling tumor cytotoxicity of rat liver macrophages mediated by liposomal muramyl dipeptide. Biochim Biophys Acta 991: 145–151 (10.1016/0304-4165(89)90040-8) / Biochim Biophys Acta by T Daemen (1989)
  39. Daemen T, Dontje BHJ, Veninga A, Scherphof GL, Oosterhuis JW (1990) Therapy of murine liver metastases by administration of MDP encapsulated in liposomes. Select Cancer Ther 6: 63–72 (10.1089/sct.1990.6.63) / Select Cancer Ther by T Daemen (1990)
  40. Damen J (1982) Interactions of liposomes with plasma lipoproteins. PhD thesis, State University, Groningen, p 80 / Interactions of liposomes with plasma lipoproteins. PhD thesis by J Damen (1982)
  41. Damen J, Waite M, Scherphof G (1979) The in vitro transfer of 14C-dimyristoyl phosphatidylcholine from liposomes to subfractions of human HDL as resolved by isoelectric focusing. FEBS Lett 105: 115–119 (10.1016/0014-5793(79)80898-4) / FEBS Lett by J Damen (1979)
  42. Damen J, Dijkstra J, Regts J, Scherphof G (1980) Effect of lipoprotein-free plasma on the interaction of human plasma high density lipoprotein with egg yolk phosphatidylcholine liposomes. Biochem Biophys Acta 620: 336–346 (10.1016/0005-2760(80)90188-5) / Biochem Biophys Acta by J Damen (1980)
  43. Damen J, Regts J, Scherphof G (1981) Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins: dependence on cholesterol and phospholipid composition. Biochem Biophys Acta 665: 538–545 (10.1016/0005-2760(81)90268-X) / Biochem Biophys Acta by J Damen (1981)
  44. Damen J, Regts J, Scherphof G (1982) Transfer of phosphatidylcholine between liposomes and human plasma high density lipoprotein: partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochem Biophys Acta 712: 444–452 (10.1016/0005-2760(82)90271-5) / Biochem Biophys Acta by J Damen (1982)
  45. Das PK, Murray GL, Zirzow GC, Brady RO, Barranger JA (1985) Lectin-specific targeting of glucocerebrosidase to different liver cells via glycosylated liposomes. Biochem Med 33: 124–131 (10.1016/0006-2944(85)90135-8) / Biochem Med by PK Das (1985)
  46. Dave J, Patel HM (1986) Differentiation in hepatic and splenic phagocytic activity during reticuloendothelial blockade with cholesterol-free and cholesterol-rich liposomes. Biochem Biophys Acta 888: 184–190 (10.1016/0167-4889(86)90020-0) / Biochem Biophys Acta by J Dave (1986)
  47. Derksen JTP, Scherphof GL (1985) An improved method for the covalent coupling of proteins to liposomes. Biochem Biophys Acta 814: 151–155 (10.1016/0005-2736(85)90430-4) / Biochem Biophys Acta by JTP Derksen (1985)
  48. Derksen JTP, Morselt HWM, Scherphof GL (1987) Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochem Biophys Acta 931: 33–40 (10.1016/0167-4889(87)90047-4) / Biochem Biophys Acta by JTP Derksen (1987)
  49. Derksen JTP, Baldeschwieler JD, Scherphof GL (1988a) In vivo stability of ester-and ether-linked phospholipid-containing liposomes as measured by perturbed angular correlation spectroscopy. Proc Natl Acad Sci USA 85: 9768–9772 (10.1073/pnas.85.24.9768) / Proc Natl Acad Sci USA by JTP Derksen (1988)
  50. Derksen JTP, Morselt HWM, Scherphof GL (1988b) Uptake and processing of immunoglobulin–coated liposomes by subpopulations of rat liver macrophages. Biochem Biophys Acta 971: 127–136 (10.1016/0167-4889(88)90184-X) / Biochem Biophys Acta by JTP Derksen (1988)
  51. Desmukh DS, Bear WD, Wisniewsky HM, Brockerhoff H (1978) Long-living liposomes as potential drug carriers. Biochem Biophys Res Commun 82: 328–334 (10.1016/0006-291X(78)90613-7) / Biochem Biophys Res Commun by DS Desmukh (1978)
  52. Desmukh DS, Bear WD, Brockerhoff H (1981) Can intact liposomes be adsorbed in the gut? Life Sci 28: 239–242 (10.1016/0024-3205(81)90728-1) / Life Sci by DS Desmukh (1981)
  53. Dijkstra J, van Galen WJM, Hulstaert CE, Kalicharan D, Roerdink, FH, Scherphof GL (1984a) Interaction of liposomes with Kupffer cells in vitro. Exp Cell Res 150: 161–176 (10.1016/0014-4827(84)90711-0) / Exp Cell Res by J Dijkstra (1984)
  54. Dijkstra J, van Galen WJM, Scherphof GL (1984b) Effects of ammonium chloride and chloroquine on endocytic uptake of liposomes by Kupffer cells in vitro. Biochem Biophys Acta 804: 58–67 (10.1016/0167-4889(84)90099-5) / Biochem Biophys Acta by J Dijkstra (1984)
  55. Dijkstra J, van Galen WJM, Scherphof G (1985b) Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles. Biochem Biophys Acta 813: 287–297 / Influence of liposome charge on the association of liposomes with Kupffer cells in vitro by J Dijkstra (1985)
  56. Dijkstra J, van Galen WJM, Scherphof G (1985c) Effects of (dihydro)cytochalasin B, colchicine, monensin and trifluoperazine on uptake and processing of liposomes by Kupffer cells in culture. Biochem Biophys Acta 845: 34–42 (10.1016/0167-4889(85)90051-5) / Biochem Biophys Acta by J Dijkstra (1985)
  57. Dragsten PR, Mitchell DB, Covert G, Baker T (1987) Drug delivery using vesicles targeted to the hepatic asialoglycoprotein receptor. Biochem Biophys Acta 926: 27–279 (10.1016/0304-4165(87)90213-3) / Biochem Biophys Acta by PR Dragsten (1987)
  58. Duzgunes N, Straubinger RM, Baldwin PA, Friend DS, Papahadjopoulos D (1985) Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry 24: 3091–3098 (10.1021/bi00334a004) / Biochemistry by N Duzgunes (1985)
  59. Ellens H, Morselt H, Scherphof G (1981) In vivo fate of large unilamellar sphingomyelin/cholesterol liposomes after intraperitoneal and intravenous injection into rats. Biochim Biophys Acta 674: 10–18 (10.1016/0304-4165(81)90341-X) / Biochim Biophys Acta by H Ellens (1981)
  60. Ellens H, Mayhew E, Rustum YM (1982) Reversible depression of the reticuloendothelial system by liposomes. Biochim Biophys Acta 714: 479–485 (10.1016/0304-4165(82)90157-X) / Biochim Biophys Acta by H Ellens (1982)
  61. Ellens H, Morselt H, Dontje BHJ, Kalicharan D, Hulstaert CE, Scherphof GL (1983) Effects of liposome dose and the presence of lymphosarcoma cells on bloodclearance and tissue distribution of large unilamellar liposomes in mice. Cancer Res 43: 2927–2934 / Cancer Res by H Ellens (1983)
  62. Ellens H, Bentz J, Szoka FC (1985) H+- and Ca2+-induced fusion and destabilization of liposomes. Biochemistry 24: 3099–3106 (10.1021/bi00334a005) / Biochemistry by H Ellens (1985)
  63. Eppstein DA, Marsh YV, van der Pas MA, Feigner PF, Schreiber AB (1985) Biological activity of liposome-encapsulated murine interferon-gamma is mediated by a cell membrane receptor. Proc Natl Acad Sci USA 82: 3688–3692 (10.1073/pnas.82.11.3688) / Proc Natl Acad Sci USA by DA Eppstein (1985)
  64. Eppstein DA, van der Pas MA, Schryver BB, Feigner PL, Gloff CA, Soike KF (1986) Controlled release and localized targeting of interferons. In: Davis SS, Ilium L, Tomlinson E (eds) Delivery systems for peptide drugs. Plenum, New York, p 227 / Delivery systems for peptide drugs by DA Eppstein (1986)
  65. Feigner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84: 7413–7417 (10.1073/pnas.84.21.7413) / Proc Natl Acad Sci USA by PL Feigner (1987)
  66. Fichtner I, Reszka R, Elbe B, Arndt D (1981) Therapeutic evaluation of liposome-encapsulated daunoblastin in murine tumor models. Neoplasma 28: 141–149 / Neoplasma by I Fichtner (1981)
  67. Fidler IJ (1980) Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science 208: 1469–1471 (10.1126/science.7384789) / Science by IJ Fidler (1980)
  68. Fidler IJ, Sone J, Fogler WE, Barnes ZL (1981) Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci USA 78: 1680–1684 (10.1073/pnas.78.3.1680) / Proc Natl Acad Sci USA by IJ Fidler (1981)
  69. Fidler IJ, Sone S, Fogler WE, Smith D, Braun DG, Tarcsay L, Gisler RJ, Schroit A (1982) Efficacy of liposomes containing a lipophilic muramyl dipeptide derivative for activating the tumoricidal properties of alveolar macrophages in vivo. J Biol Response Mod 1: 43–55 / J Biol Response Mod by IJ Fidler (1982)
  70. Fogler WE, Fidler IJ (1986) The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requries specific intracellular interaction. J Immunol 136: 2311–2317 (10.4049/jimmunol.136.6.2311) / J Immunol by WE Fogler (1986)
  71. Forssen EA, Tokes ZA (1981) Use of anionic liposomes for the reduction of chronic doxorubicin-induced cariotoxicity. Proc Natl Acad Sci USA 78: 1873–1877 (10.1073/pnas.78.3.1873) / Proc Natl Acad Sci USA by EA Forssen (1981)
  72. Fraley R, Subramani S, Papahadjopoulos D (1980) Introduction of liposome-encapsulated SV40 DNA into cells: effect of vesicle composition and incubation conditions. J Biol Chem 255: 10431–10435 (10.1016/S0021-9258(19)70482-7) / J Biol Chem by R Fraley (1980)
  73. Fraley R, Straubinger RM, Rule G, Springer E, Papahadjopoulos D (1981) Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficacy of delivery related to liptfl composition and incubation conditions. Biochemistry 20: 6978–6987 (10.1021/bi00527a031) / Biochemistry by R Fraley (1981)
  74. Fraser-Smith EB, Eppstein DA, Larsen MA, Mattews TR (1983) Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection. In feet Immun 39: 172–178 / feet Immun by EB Fraser-Smith (1983)
  75. Freise J, Mueller WH, Broelsch C, Schmidt FW (1980) In vivo distribution of liposomes between parenchymal and non-parenchymal cells in rat liver. Biomedicine 32: 118–123 / Biomedicine by J Freise (1980)
  76. Freise J, Mueller WH, Magerstedt P (1981) Uptake of liposomes and sheep red blood cells by the liver and spleen of rats with normal and decreased function of the reticuloendothelial system. Res Exp Med 178: 263–269 (10.1007/BF01851016) / Res Exp Med by J Freise (1981)
  77. Friedman M, Byers SO, Rosenman RH (1957) Resolution of aortic atherosclerotic infiltration in the rabbit by phosphatide infusion. Proc Soc Exp Biol Med 95: 586–588 (10.3181/00379727-95-23300) / Proc Soc Exp Biol Med by M Friedman (1957)
  78. Gabizon A, Papahadjopoulos D (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 85: 6949–6953 (10.1073/pnas.85.18.6949) / Proc Natl Acad Sci USA by A Gabizon (1988)
  79. Gabizon A, Dagan A, Goren D, Barenholz Y, Fuks Z (1982) Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res 42: 4734–4739 / Cancer Res by A Gabizon (1982)
  80. Gabizon A, Meshorer A, Barenholz Y (1986) Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. JNCI 77: 459–469 / JNCI by A Gabizon (1986)
  81. Gabizon A, Shiota R, Papahadjopoulos D (1989a) Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation time. JNCI 18: 1484–1488 (10.1093/jnci/81.19.1484) / JNCI by A Gabizon (1989)
  82. Gabizon A, Sulkes A, Peretz T, Druckmann S, Goren D, Amselem S, Barenholz Y (1989b) Liposome-associated doxorubicin: preclinical pharmacology and exploratory clinical phase. In: Lopez-Berestein G, Fidler IJ (eds) Liposomes in the therapy of infectious diseases and cancer. Liss, New York, p 391 / Liposomes in the therapy of infectious diseases and cancer by A Gabizon (1989)
  83. Gabizon A, Peretz T, Sulkes A, Amselem S, Ben-Yosef R, Catane R, Biran S, Barenholz Y (1900) Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (in press)
  84. Ghosh P, Das PK, Bachhawat BK (1982) Targeting of liposomes towards different cell types of rat liver through the involvement of liposomal surface glycosides. Arch Biochem Biophys 213: 266–270 (10.1016/0003-9861(82)90461-1) / Arch Biochem Biophys by P Ghosh (1982)
  85. Gilbreath MJ, Nacy CA, Hoover DL, Alving CR, Swartz GM, Meltzer MS (1985) Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes. J Immunol 134: 3420–3425 (10.4049/jimmunol.134.5.3420) / J Immunol by MJ Gilbreath (1985)
  86. Gilbreath MJ, Hoover DL, Alving CR, Swartz GM, Meltzer MS (1986) Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibiton. J Immunol 137: 1681–1687 (10.4049/jimmunol.137.5.1681) / J Immunol by MJ Gilbreath (1986)
  87. Gilbreath MJ, Fogler WE, Swartz GM, Alving CR, Meltzer MS (1989) Inhibition of interferon gamma-induced macrophage microbicidal activity agaisnt Leishmania major by liposomes: Inhibition is dependent upon composition of phospholipid headgroups and fatty acids. Int J Immunopharmacol 11: 103–110 / Inhibition of interferon gamma-induced macrophage microbicidal activity agaisnt Leishmania major by liposomes by MJ Gilbreath (1989)
  88. Gisler RH, Schumann G, Sackmann W, Pericin C, Tarcsay L, Dietrich FM (1982) A novel muramyl peptide, MTP–PE: profile of biological activities. In: Yamamura S, Kotani S (eds) Immunomodulation by microbial products and related synthetic compounds. Excerpta Medica, Amsterdam, p 167 / Immunomodulation by microbial products and related synthetic compounds by RH Gisler (1982)
  89. Graybill JR, Craven PC, Taylor RL, Williams DM, Magee WE (1982) Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis 145: 748–752 (10.1093/infdis/145.2.748) / J Infect Dis by JR Graybill (1982)
  90. Green PHR, Glickman RM, Riley JW, Quinet E (1980) Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 65: 911–919 / Human apolipoprotein A-IV by PHR Green (1980)
  91. Gregoriadis G, Neerunjun ED (1975) Homing of liposomes to target cells. Biochem Biophys Res Commun 65: 537–544 (10.1016/S0006-291X(75)80180-X) / Biochem Biophys Res Commun by G Gregoriadis (1975)
  92. Gregoriadis G, Ryman BE (1972a) Fate of protein–containing liposomes injected into rats. An approach to the treatment of storage diseases. Dur J Biochem 24: 485–491 / Fate of protein–containing liposomes injected into rats by G Gregoriadis (1972)
  93. Gregoriadis G, Ryman BE (1972b) Lysosomal localization of fructofuranosidase-containing liposomes injected into rats; implications in the treatment of genetic disorders. Biochem J 129: 123–133 (10.1042/bj1290123) / Biochem J by G Gregoriadis (1972)
  94. Gregoriadis G, Senior J (1984) Targeting of small unilamellar liposomes to the galactose receptor in vivo. Biochem Soc Trans 12: 337–339 (10.1042/bst0120337) / Biochem Soc Trans by G Gregoriadis (1984)
  95. Grosse E, Kieda C, Nicolau C (1984) Flow cytofluorimetric investigations of the uptake by hepatocytes and spleen cells of targeted and untargeted liposomes injected intravenously into mice. Biochim Biophys Acta 805: 354–361 (10.1016/0167-4889(84)90018-1) / Biochim Biophys Acta by E Grosse (1984)
  96. Gupta CM, Bali A, Dhawan S (1981) Modification of phospholipid structure results in greater stability of liposomes in serum. Biochim Biophys Acta 648: 192–198 (10.1016/0005-2736(81)90034-1) / Biochim Biophys Acta by CM Gupta (1981)
  97. Haensler J, Schuber F (1988) Preparation of neo-galactosylated liposomes and their interaction with peritoneal macrophages. Biochim Biophys Acta 946: 95–105 (10.1016/0005-2736(88)90461-0) / Biochim Biophys Acta by J Haensler (1988)
  98. Hafeman DG, Lewis JT, McConnell HM (1980) Triggering of the macrophage and neutrophil respiratory burst by antibody bound to a spin-label phospholipid hapten in model lipid bilayer membranes. Biochemistry 19: 5387–5393 (10.1021/bi00564a037) / Biochemistry by DG Hafeman (1980)
  99. Heath TD, Fraley RT, Papahadjopoulos D (1980) Antibody targeting of liposomes: cell specificity obtained by conjugation of F(ab)2 to vesicle surface. Science 210: 539–541 (10.1126/science.7423203) / Science by TD Heath (1980)
  100. Heath TD, Bragman K, Matthay K, Lopez NG, Papahadjopoulos D (1985a) Antibody-targeted liposomes: development of a cell-specific drug delivery system. In: Gregoriadis G, Poste G, Senior J, Trouet A (eds) Receptor-mediated targeting of drugs. Plenum, New York, p 407 / Receptor-mediated targeting of drugs by TD Heath (1985)
  101. Heath TD, Lopez NG, Papahadjopoulos D (1985b) The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-aspartate in vitro. Biochim Biophys Acta 820: 74–84 (10.1016/0005-2736(85)90217-2) / Biochim Biophys Acta by TD Heath (1985)
  102. Hemaker HC, Muller AD, Hermens WT, Zwaal RFA (1980) Oral treatment of haemophilia A by gastrointestinal absorption of factor VIII entrapped liposomally. Lancet 1: 70–71 (10.1016/S0140-6736(80)90495-X) / Lancet by HC Hemaker (1980)
  103. Hermetter A, Paltauf P (1983) Interaction between ether glycerophospholipid vesicles and serum proteins in vitro. Biochim Biophys Acta 752: 444–450 (10.1016/0005-2760(83)90274-6) / Biochim Biophys Acta by A Hermetter (1983)
  104. Ho RJY, Rouse BT, Huang L (1987) Target-sensitive immunoliposomes as an efficient drug carrier for antiviral activity. J Biol Chem 262: 13973–13978 (10.1016/S0021-9258(18)47890-8) / J Biol Chem by RJY Ho (1987)
  105. Hoekstra D, Tomasini R, Scherphof G (1978) Interaction of phospholipid vesicles with rat hepatocytes in primary monolayer culture. Biochim Biophys Acta 542: 456–469 (10.1016/0304-4165(78)90376-8) / Biochim Biophys Acta by D Hoekstra (1978)
  106. Hoekstra D, Tomasini R, Scherphof G (1980) Interactions of phospholipid vesicles with rat hepatocytes in vitro. Influence of vesicle-incorporated glycolipids. Biochim Biophys Acta 603: 336–346 / Interactions of phospholipid vesicles with rat hepatocytes in vitro by D Hoekstra (1980)
  107. Hoekstra D, van Renswoude J, Tomasini R, Scherphof G (1981) Interaction of phospholipid vesicles with rat hepatocytes. Further characterization of vesicle-cell surface interaction; use of serum as a physiological modulator. Membr Biochem 4: 129–147 / Interaction of phospholipid vesicles with rat hepatocytes by D Hoekstra (1981)
  108. Howard FD, Petty HR, McConnell HM (1982) Identification of phagocytosis-associated surface proteins of macrophages by two-dimensional gel electrophoresis. J Cell Biol 92: 283–288 (10.1083/jcb.92.2.283) / J Cell Biol by FD Howard (1982)
  109. Huang A, Huang L, Kennel SJ (1980) Monoclonal antibody covalently coupled with fatty acid; a reagent for in vitro liposome targeting. J Biol Chem 255: 8015–8018 (10.1016/S0021-9258(19)70595-X) / J Biol Chem by A Huang (1980)
  110. Hughes BJ, Kennel S, Lee R, Huang L (1989) Monoclonal antibody targeting of liposomes to mouse lung in vivo. Cancer Res 49: 6214–6220 / Cancer Res by BJ Hughes (1989)
  111. Hwang KJ, Luk K-FS, Beaumier PL (1980) Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study. Proc Natal Acad Sci USA 77: 4030–4034 (10.1073/pnas.77.7.4030) / Proc Natal Acad Sci USA by KJ Hwang (1980)
  112. Hwang KJ, Luk KF, Beaumier P (1982) Volume of distribution and transcapillary passage of small unilamellar liposomes. Life Sci 31: 949–955 (10.1016/0024-3205(82)90166-7) / Life Sci by KJ Hwang (1982)
  113. Ilium L, Davis SS (1984) The organ uptake of intravenously administered colloidal particles can be altered by using a non–ionic surfactant (Poloxamer 338). FEBS Lett 167: 79–82 (10.1016/0014-5793(84)80836-4) / FEBS Lett by L Ilium (1984)
  114. Ilium L, Hunneyball IM, Davis SS (1986) The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. Int J Parm 29: 53–65 (10.1016/0378-5173(86)90199-7) / Int J Parm by L Ilium (1986)
  115. Ilium L, Davis SS, Mueller RH, Mak E, West P (1987) The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized by a block polymer -poloxamine 908. Life Sci 40: 367–374 (10.1016/0024-3205(87)90138-X) / Life Sci by L Ilium (1987)
  116. Inamura N, Nakahara K, Kino T, Gotoh T, Kawamura L, Aoki H, Imanaka H, Sone S (1985) Activation of tumoricidal properties in macrophages and inhibition of experimentally induced murine metastases by a new synthetic acyltripeptide, FK- 565. J Biol Respanse Mod 4: 408–417 / J Biol Respanse Mod by N Inamura (1985)
  117. Juliano RL, Lin G (1980) The interaction of plasma proteins with liposomes: protein binding and effects on the clotting and complement system. In: Tom BH, Six HR (eds) Liposomes and immunobiology. Elsevier/North-Holland, Amsterdam, p 49 / Liposomes and immunobiology by RL Juliano (1980)
  118. Juliano RL, Stamp D (1975) The effect of particle size and charge on the clearance rates of liposomes and liposome–encapsulated drugs. Biochem Biophys Res Commun 63: 651–65 (10.1016/S0006-291X(75)80433-5) / Biochem Biophys Res Commun by RL Juliano (1975)
  119. Juliano RL, Grant CW, Barber KR, Kalp MA (1987) Mechanism of the selective toxicity of amphotericin B incorporated into liposomes. Mol Pharmacol 31: 1 (10.1016/S0026-895X(25)10311-8) / Mol Pharmacol by RL Juliano (1987)
  120. Kao YJ, Juliano RL (1981) Interactions of liposomes with the reticuloendothelial system. Effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles. Biochim Biophys Acta 677: 453–461 / Interactions of liposomes with the reticuloendothelial system by YJ Kao (1981)
  121. Kempka G, Roos PH, Kolb-Bachofen V (1990) A membrane–associated form of C- reactive protein is the galactoside-specific receptor on rat liver Kupffer cells. J Immunol 144: 1004–1009 (10.4049/jimmunol.144.3.1004) / J Immunol by G Kempka (1990)
  122. Kimelberg HK, Mayhew EG (1978) Properties and biological effects of liposomes and their uses in pharmacology and toxicology. CRC Crit Rev Toxicol 6: 25–79 (10.3109/10408447809029333) / CRC Crit Rev Toxicol by HK Kimelberg (1978)
  123. Kirby C, Gregoriadis G (1980) The effect of cholesterol content of small unilamellar liposomes on the fate of their lipid components in vivo. Life Sci 27: 2223–2230 (10.1016/0024-3205(80)90388-4) / Life Sci by C Kirby (1980)
  124. Kirby C, Gregoriadis G (1981) Plasma-induced release of solutes from small unilamellar lipsomes is associated with pore formation in the bilayer. Biochem J 199: 251–254 (10.1042/bj1990251) / Biochem J by C Kirby (1981)
  125. Kirby C, Clarke J, Gregoriadis G (1980a) Effect of cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 186: 591–598 (10.1042/bj1860591) / Biochem J by C Kirby (1980)
  126. Kirby C, Clarke J, Gregoriadis G (1980b) Cholesterol content of small unilamellar liposomes controls phosphatidylcholine loss to high density lipoproteins in the presence of serum. FEBS Lett 111: 324–328 (10.1016/0014-5793(80)80819-2) / FEBS Lett by C Kirby (1980)
  127. Koff WC, Showalter SD, Hampar B, Fidler IJ (1985) Protection of mice against fatal herpes simplex type 2 infection by liposomes containing muramyl tripeptide. Science 228: 495–497 (10.1126/science.2984772) / Science by WC Koff (1985)
  128. Kolb–Bachofen V, Schlepper-Schaefer J, Vogell W, Kolb H (1982) Electron microscopic evidence for an asialoglycoprotein receptor on Kupffer cells. Cell 21: 859–866 / Cell by Kolb–Bachofen V, Schlepper-Schaefer J, Vogell W, Kolb H (1982)
  129. Kuipers F, Spanjer HH, Havinga R, Scherphof GL, Vonk RJ (1986) Lipoproteins and liposomes as in vivo cholesterol vehicles in the rat: preferential use of cholesterol carried by small unilamellar liposomes for the formation of muricholic acids. Biochim Biophys Acta 876: 559–566 (10.1016/0005-2760(86)90044-5) / Biochim Biophys Acta by F Kuipers (1986)
  130. Lasch J, Wohlrab W (1986) Liposome-bound Cortisol: a new approach to cutaneous therapy. Biomed Biochim Acta 45: 1295–1299 / Biomed Biochim Acta by J Lasch (1986)
  131. Lazar G, van Galen M, Scherphof GL (1989) Gadoliniumchloride-induced shifts in intrahepatic distributions of liposomes. Biochim Biophys Acta 1011: 97–101 (10.1016/0167-4889(89)90194-8) / Biochim Biophys Acta by G Lazar (1989)
  132. Leserman LD, Barbet J, Kourilsky F, Weinstein JN (1980) Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antobody or protein A. Nature 288: 602–604 (10.1038/288602a0) / Nature by LD Leserman (1980)
  133. Liu D, Huang L (1989a) Role of cholesterol in the stability of pH-sensitive, large unilamellar liposomes prepared by the detergent-dialysis method. Biochim Biophys Acta 981: 254–260 (10.1016/0005-2736(89)90035-7) / Biochim Biophys Acta by D Liu (1989)
  134. Lu D, Huang L (1989b) Small but not large, unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic acid can be stabilized by human plasma. Biochemistry 28: 7700–7707 (10.1021/bi00445a027) / Biochemistry by D Lu (1989)
  135. Liu D, Zhou F, Huang L (1989) Characterization of plasma-stabilized liposomes composed of dioleoylphosphatidylethanolamine and oleic acid. Biochem Biophys Res Commun 162: 326–333 (10.1016/0006-291X(89)91999-2) / Biochem Biophys Res Commun by D Liu (1989)
  136. Lopez-Berestein G (1989) Treatment of systemic fungal infections with liposomal amphotericin B. In: Lopez-Berestein G, Fidler IJ (eds) Liposomes in the therapy of infectious diseases and cancer. Liss, New York, p 317 / Liposomes in the therapy of infectious diseases and cancer by G Lopez-Berestein (1989)
  137. Lopez-Berestein G, Fidler IJ (1989) Liposomes in the therapy of infectious diseases and cancer. Liss, New York UCLA symposia on molecular cellular biology, new series, vol 89 / Liposomes in the therapy of infectious diseases and cancer by G Lopez-Berestein (1989)
  138. Lopez-Berestein G, Mehta R, Hopfer RL, Mills K, Kasi L, Mehta K (1983) Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis 147: 939–945 (10.1093/infdis/147.5.939) / J Infect Dis by G Lopez-Berestein (1983)
  139. Lopez-Berestein G, Fainstein V, Hopfer R, Mehta K, Sullivan MP, Keating M, Rosenblum MG, Mehta R, Luna M, Hersh EM, Reuben J, Juliano RL, BodeyGP (1985) Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis 151: 704–710 / Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis by G Lopez-Berestein (1985)
  140. Mangat S, Patel HM (1985) Lymph node localization of non-specific antibody-coated liposomes. Life Sci 36: 1917–1925 (10.1016/0024-3205(85)90440-0) / Life Sci by S Mangat (1985)
  141. Martin FJ, MacDonald RC (1974) Liposomes can mimic virus membranes. Nature 252: 161–163 (10.1038/252161a0) / Nature by FJ Martin (1974)
  142. Martin FJ, Hubbell WL, Papahadjopoulos D, (1981) Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab fragments via disulfide bonds. Biochemistry 20: 4229–4238 (10.1021/bi00517a043) / Biochemistry by FJ Martin (1981)
  143. Matthay KK, Abai AM, Cobb S, Hong K, Papahadjopoulos D, Straubinger RM (1989) Role of ligand in antibody-directed endocytosis of liposomes by human T- leukemia cells. Cancer Res 49: 4879–4886 / Cancer Res by KK Matthay (1989)
  144. Mauk MR, Gamble RC, Baldeschwieler JD (1980) Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice. Proc Natl Acad Sci USA 77: 4430–4434 (10.1073/pnas.77.8.4430) / Proc Natl Acad Sci USA by MR Mauk (1980)
  145. Mayer LD, Tai LCL, Ko DSC, Masin D, Ginsberg RS, Cullis PR, Bally MB (1989) Influence of vesicle size, lipid composition and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res 49: 5922–5930 / Cancer Res by LD Mayer (1989)
  146. Mayhew E, Gotfredsen C, Schneider YJ, Trouet A (1980) Interaction of liposomes with cultured cellsa: effect of serum. Biochem Pharmacol 29: 877–886 (10.1016/0006-2952(80)90217-8) / Biochem Pharmacol by E Mayhew (1980)
  147. Mayhew E, Rustum Y, Vail WJ (1983) Inhibition of liver metastase of M5076 tumor by liposome–entrapped adriamycin. Cancer Drug Delivery 1: 43–58 (10.1089/cdd.1983.1.43) / Cancer Drug Delivery by E Mayhew (1983)
  148. Mayhew EG, Goldrosen MH, Vaage J, Rustum YM (1987) Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38. 78: 707–713 / Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and by EG Mayhew (1987)
  149. McDougall IR, Dunnick JK, McNamee MG, Kriss JP (1974) Distribution and fate of synthetic lipid vesicles in the mouse. A combined radionuclide and spin label study. Proc Natl Acad Sci USA 71: 3487–3491 / Distribution and fate of synthetic lipid vesicles in the mouse by IR McDougall (1974)
  150. Mehta K, Lopez–Berestein G, Hersh G, Juliano RL (1982) Uptake of liposomes and Iiposome-encapsulated muramyl dipeptide by human peripheral blood monocytes. J Reticuloendothel Soc 32: 155–164 / Uptake of liposomes and Iiposome-encapsulated muramyl dipeptide by human peripheral blood monocytes. J Reticuloendothel Soc by K Mehta (1982)
  151. Mehta R, Lopez-Berestein G, Hopfer RL, Mills K, Juliano RL (1984) Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim Biophys Acta 770: 230–234 (10.1016/0005-2736(84)90135-4) / Biochim Biophys Acta by R Mehta (1984)
  152. Moghimi SM, Patel HM (1988) Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett 233: 143–147 (10.1016/0014-5793(88)81372-3) / FEBS Lett by SM Moghimi (1988)
  153. Moghimi SM, Patel HM (1989a) Differential properties of organ-specific serum opsonins for liver and spleen macrophages. Biochim Biophys Acta 984: 379–383 (10.1016/0005-2736(89)90306-4) / Biochim Biophys Acta by SM Moghimi (1989)
  154. Moghimi SM, Patel HM (1989b) Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. Biochim Biophys Acta 984: 384–387 (10.1016/0005-2736(89)90307-6) / Biochim Biophys Acta by SM Moghimi (1989)
  155. Muller CD, Schuber F (1989) Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages. Biochim Biophys Acta 986: 97–105 (10.1016/0005-2736(89)90277-0) / Biochim Biophys Acta by CD Muller (1989)
  156. Munn MW, Parce JW (1982) Antibody-dependent phagocytosis of haptenated liposomes by human neutrophils is dependent on the physical state of the liposomal membrane. Biochim Biophys Acta 692: 101–108 (10.1016/0005-2736(82)90507-7) / Biochim Biophys Acta by MW Munn (1982)
  157. Nayar R, Schroit AJ (1985) Generation of pH-sensitive liposomes:use of large unilamellar vesicles containing N-succinyldioleoylphosphatidylethanolamine. Biochemistry 24: 5967–5971 (10.1021/bi00342a042) / Biochemistry by R Nayar (1985)
  158. New RRC, Chance ML, Thomas SC, Peters W (1978) Antileishmanial activity of antimonials entrapped in liposomes. Nature 272: 55–56 (10.1038/272055a0) / Nature by RRC New (1978)
  159. New RRC, Black CDV, Parker RJ, Scherphof (1990) Liposomes in biological systems. In: New RRC (ed) Liposomes, a practical approach. IRL, Oxford, p 221 / Liposomes, a practical approach by RRC New (1990)
  160. Olson F, Mayhew E, Maslow D, Rustum Y, Szoka FC (1982) Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur J Cancer Clin Oncol 18: 167–176 (10.1016/0277-5379(82)90060-8) / Eur J Cancer Clin Oncol by F Olson (1982)
  161. Pabst MJ, Cummings NP, Shiba T, Kusomoto S, Kotani S (1980) Lipophilic derivative of muramyldipeptide is more active than muramyl dipeptide in priming macrophages to release superoxide anion. Infect Immun 29: 617 (10.1128/iai.29.2.617-622.1980) / Infect Immun by MJ Pabst (1980)
  162. Pagano RE, Huang L (1975) Interactions of phospholipid vesicles with cultured mammalian cells. II. Studies of mechanism. J Cell Biol 67: 49–60 / Interactions of phospholipid vesicles with cultured mammalian cells. II by RE Pagano (1975)
  163. Pagano RE, Weinstein JN (1978) Interactions of liposomes with mammalian cells. Annu Rev Biophys Bioeng 7: 435–468 (10.1146/annurev.bb.07.060178.002251) / Annu Rev Biophys Bioeng by RE Pagano (1978)
  164. Papahadjopoulos D, Gabizon A (1987) Targeting of liposomes to tumor cells in vivo. Ann NY Acad Sci 507: 64–74 (10.1111/j.1749-6632.1987.tb45792.x) / Ann NY Acad Sci by D Papahadjopoulos (1987)
  165. Papahadjopoulos D, Poste G, Mayhew E (1974) Cellular uptake of cyclic AMP captured within phospholipid vesicles and effect on cell growth behaviour. Biochim Biophys Acta 363: 404–418 (10.1016/0005-2736(74)90079-0) / Biochim Biophys Acta by D Papahadjopoulos (1974)
  166. Parker RJ, Priester ER, Sieber SM (1982a) Comparison of lymphatic uptake metabolism, excretion and biodistribution of free and liposome-entrapped [14C] cytosine-D-arabinofuranoside following intraperitoneal administration to rats. Drug Metab Dispos 10: 40–45 (10.1016/S0090-9556(25)07833-X) / Drug Metab Dispos by RJ Parker (1982)
  167. Parker RJ, Priester ER, Sieber SM (1982b) Effect of route of administration and liposome entrapment on the metabolism and disposition of adriamycin in the rat. Durg Metab Dispos 10: 499–504 (10.1016/S0090-9556(25)07922-X) / Durg Metab Dispos by RJ Parker (1982)
  168. Patel HM, Wild AE (1988) Fc receptor–mediated transcytosis of IgG-coated Liposomes across epithelial barriers. FEBS Lett 234: 321–325 (10.1016/0014-5793(88)80108-X) / FEBS Lett by HM Patel (1988)
  169. Patel HM, Tuzel NS, Ryman BE (1983a) Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen. Biochim Biophys Acta 761: 142–151 (10.1016/0304-4165(83)90223-4) / Biochim Biophys Acta by HM Patel (1983)
  170. Patel KR, Li MP, Baldeschwieler JD (1983b) Suppression of liver uptake of liposomes by dextran sulfate 500. Proc Natl Acad Sci USA 80: 6518–6522 (10.1073/pnas.80.21.6518) / Proc Natl Acad Sci USA by KR Patel (1983)
  171. Patel HM, Boodle KM, Vaughan–Jones R (1984) Assessment of the potential use of liposomes for lymphoscintigraphy and lymphatic drug delivery. Failure of 99m-technetium marker to represent intact liposomes in lymph nodes. Biochim Biophys Acta 801: 76–86 / Assessment of the potential use of liposomes for lymphoscintigraphy and lymphatic drug delivery. Failure of 99m-technetium marker to represent intact liposomes in lymph nodes. Biochim Biophys Acta by HM Patel (1984)
  172. Patel HM, Tuzel NS, Stevenson WS (1985) Intracellular digestion of saturated and unsaturated phospholipid liposomes by mucosal cells. Possible mechanism of transport of liposomally entrapped macromolecules across the isolated vascularly perfused rabbit ileum. Biochim Biophys Acta 839: 40–49 / Intracellular digestion of saturated and unsaturated phospholipid liposomes by mucosal cells by HM Patel (1985)
  173. Peeters PAM, Brunink BG, Eling WMC, Crommelin DJA (1989) Therapeutic effect of chloroquin (CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ. Biochim Biophys Acta 981: 269–276 (10.1016/0005-2736(89)90037-0) / Biochim Biophys Acta by PAM Peeters (1989)
  174. Phillips NC, Tsao M-S (1989) Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptide. Cancer Immunol Immunother 28: 54–58 / Cancer Immunol Immunother by NC Phillips (1989)
  175. Phillips NC, Moras ML, Chedid L, Bernard JM (1985) Activation of alveolar macrophage tumoricidal activity and eradication of experimental pulmonary metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derviative. Cancer Res 45: 128–134 / Cancer Res by NC Phillips (1985)
  176. Phillips NC, Rioux J, Tsao M-S (1988) Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide. Hepatology 8: 1046–1050 (10.1002/hep.1840080511) / Hepatology by NC Phillips (1988)
  177. Poste G, Papahadjopoulos D (1976) Lipid vesicles as carriers for introducing materials into cultured cells. Influence of vesicle lipid on mechanism(s) of vesicle incorporation into cells. Proc Natl Acad Sci USA 73: 1603–1607 / Lipid vesicles as carriers for introducing materials into cultured cells by G Poste (1976)
  178. Poste G, Kirsh R, Fogler WE, Fidler IJ (1979) Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. Cancer Res 39: 881–892 / Cancer Res by G Poste (1979)
  179. Poste G, Bucana C, Raz A, Bugelski P, Kirsh R, Fidler IJ (1982) Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res 42: 1412–1422 / Cancer Res by G Poste (1982)
  180. Poste G, Kirsh R, Koestler T (1984) The challenge of liposome targeting in vivo. In: Gregoriadis G (ed) Liposome technology, vol 3. CRC, Boca Raton, p 1 / Liposome technology by G Poste (1984)
  181. Proffitt RT, Williams LE, Presant CA, Tin GW, Uliana JA Gamble RC, Baldeschwieler JD (1983) Tumor-imaging potential of liposomes loaded with mIn–NTA. Biodistribution in mice. J Nucl Med 24: 45–51 / Tumor-imaging potential of liposomes loaded with mIn–NTA by RT Proffitt (1983)
  182. Rahman A, Kessler A, More N, Sikic B, Rowden G, Woolley P, Schein P (1980) Liposomal protection of Adriamycin-induced cardiotoxicity in mice. Cancer Res 40: 1532–1637 / Cancer Res by A Rahman (1980)
  183. Rahman YE, Cerny EA, Patel KR, Lau EH, Wright BJ (1982) Differential uptake of liposomes varying in size and lipid composition by parenchymal and Kupffer cells of mouse liver. Life Sci 31: 2061–2071 (10.1016/0024-3205(82)90098-4) / Life Sci by YE Rahman (1982)
  184. Rahman A, Carmichael D, Harris M, Roh JK (1986) Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Cancer Res 43: 2295–2299 / Cancer Res by A Rahman (1986)
  185. Rahman A, Roh JK, Treat J (1989) Preclinical and clinical pharmacology of doxorubicin entrapped in cardiolipin liposomes. In: Lopez-Berestein G, Fidler IJ (eds) Liposomes in the therapy of infectious diseases and cancer. Liss, New York, p 367 / Liposomes in the therapy of infectious diseases and cancer by A Rahman (1989)
  186. Raz A, Bucana C, Fogler WE, Poste G, Fidler IJ (1981) Biochemical, morphological and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res 41: 487–494 / Cancer Res by A Raz (1981)
  187. Roerdink FH, Wisse E, Morselt HWM, van der Meulen J, Scherphof GL (1977) Cellular distribution of intravenously injected protein-containing liposomes in the rat liver. In: Wisse E, Knook DL (eds) Kupffer cells and other liver sinusoidal cells. Elsevier/North-Holland, Amsterdam, p 263 / Kupffer cells and other liver sinusoidal cells by FH Roerdink (1977)
  188. Roerdink FH, Dijkstra J, Hartman G, Bolscher B, Scherphof G (1981) The involvement of parenchymal, Kupffer and endothelial liver cells in hepatic uptake of intravenously injected liposomes. Effects of lanthanum and godolinium salts. Biochim Biophys Acta 677: 79–89 / The involvement of parenchymal, Kupffer and endothelial liver cells in hepatic uptake of intravenously injected liposomes by FH Roerdink (1981)
  189. Roerdink FH, Regts J, van Leeuwen B, Scherphof GL (1984) Intrahepatic uptake and processing of intravenously injected small unilamellar vesicles in rats. Biochim Biophys Acta 770: 195–202 (10.1016/0005-2736(84)90130-5) / Biochim Biophys Acta by FH Roerdink (1984)
  190. Roerdink FH, Regts J, Scherphof G (1986) Effect of lipid composition on the uptake and intracellular degradation of liposomes by Kupffer cells. In: Kirn A, Knook DL, Wisse E (eds) Cell of the hepatic sinusoid. Kupffer Cell Foundation, Rijswijk, p 125 / Cell of the hepatic sinusoid by FH Roerdink (1986)
  191. Roerdink FH, Regts J, Handel T, Sullivan SM, Baldeschwieler JD, Scherphof GL (1989) Effect of cholesterol on the uptake and intracellular degradation of liposomes by liver and spleen: a combined biochemical and x-ray perturbed angular correlation study. Biochim Biophys Acta 980: 234–240 (10.1016/0005-2736(89)90404-5) / Biochim Biophys Acta by FH Roerdink (1989)
  192. Rowland RN, Woodley JF (1980) The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. Biochim Biophys Acta 620: 400–409 (10.1016/0005-2760(80)90131-9) / Biochim Biophys Acta by RN Rowland (1980)
  193. Rowland RN, Woodley JF (1981) The uptake of distearoylphosphatidylcholine/ cholesterol liposomes by rat intestinal sacs in vitro. Biochim Biophys Acta 673: 217–223 (10.1016/0304-4165(81)90329-9) / Biochim Biophys Acta by RN Rowland (1981)
  194. Rudra D, Myant N, Pflug J, Reichl D (1984) The distribution of cholesterol and apolipoprotein A-l between the lipoproteins in plasma and peripheral lymph from normal human subjects. Atherosclerosis 53: 297–308 (10.1016/0021-9150(84)90130-8) / Atherosclerosis by D Rudra (1984)
  195. Rustum YM (1983) Prodrugs: an approach to target-directed chemotherapy. In: Cheng Y-C, et al. (eds) Development of target-oriented anticancer drugs. Raven, New York, p 119 / Development of target-oriented anticancer drugs by YM Rustum (1983)
  196. Salord J, Schuber F (1988) In vitro drug delivery mediated by ecto-NAD+-glyco-hydrolase ligand-targeted liposomes. Biochim Biophys Acta 971: 197–206 (10.1016/S0005-2728(88)80107-5) / Biochim Biophys Acta by J Salord (1988)
  197. Salord J, Tarnus C, Muller CD, Schuber F (1986) Targeting of liposomes by covalent coupling with ecto-NAD+-glycohydrolase ligands. Biochim Biophys Acta 886: 64–75 (10.1016/0167-4889(86)90212-0) / Biochim Biophys Acta by J Salord (1986)
  198. Scherphof G, Morselt H (1984) On the size dependent disintegration of samll unilamellar phosphatidylcholine vesicles in rat plasma. Evidence of complete loss of vesicle structure. Biochem J 221: 423–429 / On the size dependent disintegration of samll unilamellar phosphatidylcholine vesicles in rat plasma by G Scherphof (1984)
  199. Scherphof G, Roerdink F, Waite M, Parks J (1978) Disintegration of phosphatidylcholine liposomes as a result of interaction with high density lipoproteins. Biochim Biophys Acta 542: 296–307 (10.1016/0304-4165(78)90025-9) / Biochim Biophys Acta by G Scherphof (1978)
  200. Scherphof G, Morselt H, Regts J, Wilschut J (1979) The involvement of the lipid phase transition in the plasma-induced dissolution of multilamellar phosphatidylcholine vesicles. Biochim Biophys Acta 556: 196–207 (10.1016/0005-2736(79)90042-7) / Biochim Biophys Acta by G Scherphof (1979)
  201. Scherphof G, Roerdink F, Hoekstra D, Zborowski J, Wisse E (1980) Stability of liposomes in presence of blood constituents: consequences for uptake of liposomal lipid and entrapped compounds by rat liver cells. In: Gregoriads G, Allison AC (eds) Liposomes in biological systems. Wiley, Chichester, p 179 / Liposomes in biological systems by G Scherphof (1980)
  202. Scherphof G, Roerdink F, Dijkstra J, Ellens H, de Zanger R, Wisse E (1983a) Uptake of liposomes by rat and mouse hepatocytes and Kupffer cells. Biol Cell 47: 47–58 / Uptake of liposomes by rat and mouse hepatocytes and Kupffer cells. Biol Cell by G Scherphof (1983)
  203. Scherphof G, van Leeuwen B, Wilschut J, Damen J (1983b) Exchange of phosphatidylcholine between small unilamellar liposomes and human high density lipoprotein exclusively involves the phospholipid in the outer monolayer of the liposomal membrane. Biochim Biophys Acta 732: 595–599 (10.1016/0005-2736(83)90236-5) / Biochim Biophys Acta by G Scherphof (1983)
  204. Schroit AJ, Fidler IJ (1982) Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res 42: 161–167 / Cancer Res by AJ Schroit (1982)
  205. Schwendener RA, Lagocki PA, Rahman YE (1984) The effects of charge and size on the interaction of unilamellar liposomes with macrophages. Biochim Biophys Acta 772: 93–101 (10.1016/0005-2736(84)90521-2) / Biochim Biophys Acta by RA Schwendener (1984)
  206. Sculier JP, Coune A, Brassine C, Laduron C, Atassi G, Ruysschaert JM, Fruehling J (1986) Intravenous infusion of high doses of liposomes containing NCC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data. J Clin Oncol 4: 789–797 / Intravenous infusion of high doses of liposomes containing NCC 251635, a water-insoluble cytostatic agent by JP Sculier (1986)
  207. Senior JH (1987) Fate and behaviour of liposomes in vivo: a review of controlling factors. CRC Crit Rev Ther Drug Carrier Syst 3: 123–193 / CRC Crit Rev Ther Drug Carrier Syst by JH Senior (1987)
  208. Senior J, Gregoriadis G (1982a) Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci 30: 2133–2136 (10.1016/0024-3205(82)90455-6) / Life Sci by J Senior (1982)
  209. Senior J, Gregoriadis G (1982b) Is the half-life circulating liposomes determined by changes in their permeability? FFBS Lett 145: 109–114 (10.1016/0014-5793(82)81216-7) / FFBS Lett by J Senior (1982)
  210. Senior J, Gregoriadis G (1984) Methodology in assessing liposomal stability in the presence of blood, clearance from the circulation of injected animals, and uptake by tissues. In: Gregoriadis G (ed) Liposome technology, vol 3. CRC, Boca Raton, p 263 / Liposome technology by J Senior (1984)
  211. Senior J, Gregoriadis G, Mitropoulos KA (1983) Stability and clearance of small unilamellar liposomes. Studies with normal and lipoprotein–deficient mice. Biochim Biophys Acta 760: 111–118 / Stability and clearance of small unilamellar liposomes by J Senior (1983)
  212. Senior J, Crawley JCW, Gregoriadis G (1985) Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim Biophys Acta 839: 1–8 (10.1016/0304-4165(85)90174-6) / Biochim Biophys Acta by J Senior (1985)
  213. Souhami RL, Patel HM, Ryman BE (1981) The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochim Biophys Acta 674: 354–371 (10.1016/0304-4165(81)90366-4) / Biochim Biophys Acta by RL Souhami (1981)
  214. Spanjer H, Scherphof G (1983) Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo. Biochim Biophs Acta 734: 40–47 (10.1016/0005-2736(83)90072-X) / Biochim Biophs Acta by H Spanjer (1983)
  215. Spanjer H, Morselt H, Scherphof G (1984) Lactosylceramide-induced stimulation of liposome uptake by Kupffer cells in vivo. Biochim Biophys Acta 774: 49–55 (10.1016/0005-2736(84)90273-6) / Biochim Biophys Acta by H Spanjer (1984)
  216. Spanjer HH, Scherphof GL, van Berkel TJC, Kempen HJM (1985) The effect of a water-soluble tris-galactoside terminated cholesterol derivative on the in vivo fate of small unilamellar vesicles in rats. Biochim Biophys Acta 816: 396–402 (10.1016/0005-2736(85)90507-3) / Biochim Biophys Acta by HH Spanjer (1985)
  217. Spanjer HH, van Galen M, Roerdink FH, Regts J, Scherphof GL (1986) Intrahepatic distribution os small unilamellar liposomes as a function of liposomal lipid composition. Biochim Biophys Acta 863: 224–230 (10.1016/0005-2736(86)90262-2) / Biochim Biophys Acta by HH Spanjer (1986)
  218. Stein O, Halperin G, Leitersdorf E, Olivecrona T, Stein Y (1984b) Lipoprotein lipase mediated uptake of non-degradable ether analogues of phosphatidylcholine and cholesteryl ester by cultured cells. Biochim Biophys Acta 795: 47–59 (10.1016/0005-2760(84)90103-6) / Biochim Biophys Acta by O Stein (1984)
  219. Stein Y, Halperin G, Leitersdorf E, Dabach Y, Hollander G, Stein O (1984a) Metabolism of liposomes prepared from a labelled ether analog of 1,2-dioleoyl-M-glycero-3-phosphocholine in the rat. Biochim Biophys Acta 793: 354–364 (10.1016/0005-2760(84)90249-2) / Biochim Biophys Acta by Y Stein (1984)
  220. Stevenson RW, Patel HM, Parsons JA, Ryman BE (1982) Prolonged hypoglycemic effect in diabetic dogs due to subcutaneous administration of insulin in liposomes. Diabetes 31: 506–511 (10.2337/diab.31.6.506) / Diabetes by RW Stevenson (1982)
  221. Storm G, Roerdink FH, Steerenberg PA, de Jong WH, Crommelin DJA (1987) Influence of lipid composition on the antitumor activity exerted by doxorubicin– containing liposomes in a rat solid tumor model. Cancer Res 47: 3366–3372 / Influence of lipid composition on the antitumor activity exerted by doxorubicin– containing liposomes in a rat solid tumor model. Cancer Res by G Storm (1987)
  222. Storm G, Nassander UH, Roerdink FH, Steerenberg PA, de Jong WH, Crommelin DJA (1989) In: Lopez-Berestein G, Fidler IJ (eds) Liposomes in the therapy of infectious diseases and cancer. Liss, New York, p 105 / Liposomes in the therapy of infectious diseases and cancer by G Storm (1989)
  223. Straubinger RM, Hong K, Friend DS, Papahadjopoulos D (1983) Endocytosis of liposomes and intracellular fate of encapsualted molecules: encounter with a low-pH compartment after internalization in coated vesicles. Cell 43: 1069–1079 (10.1016/0092-8674(83)90291-X) / Cell by RM Straubinger (1983)
  224. Stukart MJ, Rijnsent A, Roose (1987) Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma interferon supplemented with lipopolysaccharide or muramyl dipeptide. Cancer Res 47: 3880–3885 / Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma interferon supplemented with lipopolysaccharide or muramyl dipeptide. Cancer Res by MJ Stukart (1987)
  225. Sunamoto J, Iwamoto K (1986) Protein-coated and polysaccharide-coated liposomes as drug carriers. CRC Crit Rev Ther Drug Carrier Syst 2: 117–136 / CRC Crit Rev Ther Drug Carrier Syst by J Sunamoto (1986)
  226. Sunamoto J, Goto M, Iida T, Hara K, Saito A, Tomonaga A (1984) Unexpected tissue distribution of liposomes coated with amylopectin derivatives and successful use in the treatment of experimental legionnaires disease. In: Gregoriadis G, Poste G, Senior J, Trouet (eds) Receptor-mediated targeting of drugs. Plenum, New York, p 359 (10.1007/978-1-4684-4862-7_20) / Receptor-mediated targeting of drugs by J Sunamoto (1984)
  227. Szoka FC, Mayhew E (1983) Alteration of liposome disposition in vivo by bilayer situated carbohydrates. Biochem Biophys Res Commun 110: 140–146 (10.1016/0006-291X(83)91271-8) / Biochem Biophys Res Commun by FC Szoka (1983)
  228. Szoka FG, Jacobson K, Derzko Z, Papahadjopoulos D (1980) Fluorescence studies on the mechanism of liposome-cell interactions in vitro. Biochim Biophys Acta 600: 1–18 (10.1016/0005-2736(80)90406-X) / Biochim Biophys Acta by FG Szoka (1980)
  229. Szoka FC, Magnusson K-E, Wojcieszyn J, Hou Y, Derzko Z, Jacobson K (1981) Use of lectins and polyethylene glycol for fusion of glycolipid-containing liposomes with eukaryotic cells. Proc Natal Acad Sci USA 78: 1685–1689 (10.1073/pnas.78.3.1685) / Proc Natal Acad Sci USA by FC Szoka (1981)
  230. Takada M, Yuzuriha T, Katayama K, Iwamoto K, Sunamoto J (1984) Increased lung uptake of liposomes coated with polysaccharides. Biochim Biophys Acta 802: 237–243 (10.1016/0304-4165(84)90167-3) / Biochim Biophys Acta by M Takada (1984)
  231. Thombre PS, Deodhar SD (1984) Inhibition of liver metastases in murine colon adenocarcinoma by liposomes containing human C-reactive protein or crude lymphokine. Cancer Immunol Immunother 16: 145–150 (10.1007/BF00205420) / Cancer Immunol Immunother by PS Thombre (1984)
  232. Tomonaga A, Ueda Y, Hirota M, Saito A, Hara K, Goto M, Sunamoto J (1985) The uptake of polysaccharide-coated liposomes by alveolar macrophages. In: Leichard S, Kojima M (eds) Macrophage biology. Liss, New York, p 15 / Leichard S by A Tomonaga (1985)
  233. Torchilin VP (1987) Liposomes as targetable drug carriers. CRC Crit Rev Ther Drug Carrier Syst 2: 65–115 / CRC Crit Rev Ther Drug Carrier Syst by VP Torchilin (1987)
  234. Torchilin VP, Goldmacher VS, Smirnov VN (1978) Comparative studies on covalent and non-covalent immobilization of protein molecules on the surface of liposomes. Biochem Biophys Res Commun 85: 983–990 (10.1016/0006-291X(78)90640-X) / Biochem Biophys Res Commun by VP Torchilin (1978)
  235. Torchilin VP, Klibanov Al, Smirnov VN (1982) Phosphatidylinositol may serve as the hydrophobic anchor for immobilization of proteins on liposome surface. FEBS Lett 138: 117–120 (10.1016/0014-5793(82)80408-0) / FEBS Lett by VP Torchilin (1982)
  236. Treat J, Greenspan AR, Rahman A (1989) Liposome-encapsulated doxorubicin. Preliminary results of phase I and phase II trials. In: Lopez-Berestein G, Fidler IJ (eds) Liposomes in the therapy of infectious diseases and cancer. Liss, New York, p 353 / Liposomes in the therapy of infectious diseases and cancer by J Treat (1989)
  237. Tremblay C, Barza M, Fiore C, Szoka F (1984) Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob Agents Chemother 26: 170–173 (10.1128/AAC.26.2.170) / Antimicrob Agents Chemother by C Tremblay (1984)
  238. Turner A, Kirby C, Senior J, Gregoriadis G (1983) Fate of cholesterol-rich liposomes after subcutaneous injection into rats. Biochim Biophys Acta 760: 119–125 (10.1016/0304-4165(83)90132-0) / Biochim Biophys Acta by A Turner (1983)
  239. Van Borssum Waalkes M, Scherphof GL (1990) Liposome–incorporated 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine as a slow-release antitumor drug depot in rat liver macrophages. Select Cancer Ther 6: 15–22 (10.1089/sct.1990.6.15) / Select Cancer Ther by M Borssum Waalkes Van (1990)
  240. Van Hoesel QG, Steerenberg PA, Crommelin DJA, van Dijk A, van Oort W, Klein S, Doux JMC, de Wildt DJ, Hillen FC (1984) Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsi rat. Cancer Res 44: 3698–3705 / Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsi rat. Cancer Res by QG Hoesel Van (1984)
  241. Van Oss CJ, Gillman CF, Bronson PM, Border JR (1974a) Phagocytosis–inhibiting properties of human serum alpha-1 acid glycoprotein. Immunol Commun 3: 321–328 (10.3109/08820137409061112) / Immunol Commun by CJ Oss Van (1974)
  242. Van Oss CJ, Gillman CF, Bronson PM, Border JR (1974b) Opsonic properties of human serum alpha–2 HS glycoprotein. Immunol Commun 3: 329–326 (10.3109/08820137409061113) / Immunol Commun by CJ Oss Van (1974)
  243. Van Renswoude AJBM, Westenberg P, Scherphof GL (1979) In vitro interaction of Zajdela ascites hepatoma cells with lipid vesicles. Biochim Biophys Acta 558: 22–40 (10.1016/0005-2736(79)90312-2) / Biochim Biophys Acta by AJBM Renswoude Van (1979)
  244. Van Renswoude J, Bridges KR, Harford JB, Klausner RD (1982) Receptor–mediated endocytosis of transferrin and the uptake of Fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc Natl Acad Sci USA 79: 6186–6190 (10.1073/pnas.79.20.6186) / Proc Natl Acad Sci USA by J Renswoude Van (1982)
  245. Van Rooijen N, van Nieuwmegen R (1984) Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. Cell Tissue Res 238: 355–358 (10.1007/BF00217308) / Cell Tissue Res by N Rooijen Van (1984)
  246. Van Rooijen N, van Nieuwmegen R, Kamperdijk EWA (1985) Elimination of phagocytic cells after intravenous injection of liposome-encapsulated dichloromethylene phosphonate. Ultrastructural aspects of elimination of marginal zone macrophages. Virchows Arch [Cell Pathol] 49: 375–383 / Elimination of phagocytic cells after intravenous injection of liposome-encapsulated dichloromethylene phosphonate by N Rooijen Van (1985)
  247. Weinstein JN, Leserman LD (1984) Liposomes as drug carriers in cancer chemotherapy. Pharmacol Ther 24: 207–233 (10.1016/0163-7258(84)90035-4) / Pharmacol Ther by JN Weinstein (1984)
  248. Weinstein JN, Blumenthal R, Sharrow SO, Henkart P (1978) Antibody-mediated targeting of liposomes: binding to lymphocytes does not ensure incorporation of vesicle contents into the cells. Biochim Biophys Acta 509: 272 (10.1016/0005-2736(78)90047-0) / Biochim Biophys Acta by JN Weinstein (1978)
  249. Weissman G, Korchak H, Finkelstein M, Smolen J, Hoffstein S (1978) Uptake of enzyme-laden liposomes by animal cells in vitro and in vivo. Ann NY Acad Sci 308: 235–249 (10.1111/j.1749-6632.1978.tb22026.x) / Ann NY Acad Sci by G Weissman (1978)
  250. Wisse E, de Zanger R, Jacobs R (1982) Lobular gradients in endothelial fenestrae and sinusoidal diameter favour centrolobular exchange processes: a scanning EM study. In: Knook DL, Wisse E (eds) Sinusoidal liver cells. Elsevier, Amsterdam, p 61 / Sinusoidal liver cells by E Wisse (1982)
  251. Wisse E, de Zanger RB, Jacobs R, McCuskey RS (1983) Scanning electron micro-scope observations on the structure of portal veins, sinusoids and central veins in rat liver. Scanning electron Microsc 3: 1441–1452 / Scanning electron Microsc by E Wisse (1983)
  252. Woodley JF (1986) Liposomes for oral administration of drugs. Crit Rev Ther Drug Carrier Syst 2: 1–18 / Crit Rev Ther Drug Carrier Syst by JF Woodley (1986)
  253. Wright S, Huang L (1989) Antibody–directed liposomes as drug-delivery vehicles. Adv Drug Delivery Rev 3: 343–389 (10.1016/0169-409X(89)90027-6) / Adv Drug Delivery Rev by S Wright (1989)
  254. Wu MS, Robbins JC, Bugianesi RL, Ponpipom MM, Shen TY (1981) Modified in vivo behaviour of liposomes containing synthetic glycolipids. Biochim Biophys Acta 674: 19–29 (10.1016/0304-4165(81)90342-1) / Biochim Biophys Acta by MS Wu (1981)
  255. Zborowski J, Roerdink FH, Scherphof GL (1977) Leakage of sucrose from phos-phatidylcholine liposomes induced by interaction with serum albumin. Biochim Biophys Acta 497: 183–191 (10.1016/0304-4165(77)90151-9) / Biochim Biophys Acta by J Zborowski (1977)
Dates
Type When
Created 13 years, 9 months ago (Nov. 17, 2011, 8:30 a.m.)
Deposited 5 months, 3 weeks ago (March 14, 2025, 1:16 a.m.)
Indexed 1 month ago (Aug. 2, 2025, 1:06 a.m.)
Issued 34 years, 8 months ago (Jan. 1, 1991)
Published 34 years, 8 months ago (Jan. 1, 1991)
Published Print 34 years, 8 months ago (Jan. 1, 1991)
Funders 0

None

@inbook{Scherphof_1991, title={In Vivo Behavior of Liposomes: Interactions with the Mononuclear Phagocyte System and Implications for Drug Targeting}, ISBN={9783642758621}, ISSN={0171-2004}, url={http://dx.doi.org/10.1007/978-3-642-75862-1_8}, DOI={10.1007/978-3-642-75862-1_8}, booktitle={Targeted Drug Delivery}, publisher={Springer Berlin Heidelberg}, author={Scherphof, G. L.}, year={1991}, pages={285–327} }